Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Campagnolo

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neurology|October 31, 2008
Comorbidity delays diagnosis and increases disability at diagnosis in MSR A Marrie, R Horwitz, G Cutter, et al.
Neurology|October 12, 2005
Changes in the ascertainment of multiple sclerosisR A Marrie, G Cutter, T Tyry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreatedR A Marrie, R Horwitz, G Cutter, et al.
Neurology|March 31, 2010
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosisR A Marrie, R Rudick, R Horwitz, et al.
Surgery|December 1, 1987
Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinomaD Campagnolo, W R Gower, P J Fabri, et al.
Journal of Neurology|October 16, 2008
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MSD L Arnold, D Campagnolo, H Panitch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2008
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosisT Vollmer, H Panitch, A Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?A Bar-Or, J Oger, E Gibbs, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neurology|October 31, 2008
Comorbidity delays diagnosis and increases disability at diagnosis in MSR A Marrie, R Horwitz, G Cutter, et al.
Neurology|October 12, 2005
Changes in the ascertainment of multiple sclerosisR A Marrie, G Cutter, T Tyry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2009
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreatedR A Marrie, R Horwitz, G Cutter, et al.
Neurology|March 31, 2010
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosisR A Marrie, R Rudick, R Horwitz, et al.
Surgery|December 1, 1987
Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinomaD Campagnolo, W R Gower, P J Fabri, et al.
Journal of Neurology|October 16, 2008
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MSD L Arnold, D Campagnolo, H Panitch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2008
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosisT Vollmer, H Panitch, A Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?A Bar-Or, J Oger, E Gibbs, et al.
Pageof 2